Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2001 | 12-2000 | 12-1999 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 25,979 | 3,771 | N/A |
| Receivables | 9,671 | 9,640 | N/A |
| Inventories | 13,437 | 11,179 | N/A |
| Other current assets | 9,712 | 7,026 | 0 |
| TOTAL | $58,799 | $31,616 | $N/A |
| Non-Current Assets | |||
| PPE Net | 269,323 | 238,850 | N/A |
| TOTAL | $269,323 | $238,850 | $N/A |
| Total Assets | $352,456 | $295,381 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| TOTAL | $63,730 | $54,730 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 10,000 | 51,000 | N/A |
| Other Non-Current Liabilities | 1,329 | 1,469 | 0 |
| TOTAL | $11,329 | $52,469 | $N/A |
| Total Liabilities | $95,926 | $128,124 | $N/A |
| Shareholders' Equity | |||
| Retained earnings | 79,007 | 52,849 | N/A |
| Other shareholders' equity | 177,523 | 114,408 | 0 |
| TOTAL | $256,530 | $167,257 | $N/A |
| Total Liabilities And Equity | $352,456 | $295,381 | $0 |